lists patented inventions available for sale or licensing. Inventors can list their patented inventions (or patent pending) for sale. New inventions for sale are added on a daily basis !
Home    List your patent    My account     Help     Support us    


[Category : - HEALTH- Organic Chemistry]
[Viewed 1751 times]

ILV5 is exclusive enzyme in production of aliphatic aminoacids like Leucine and Isoleucine, this enzyme does not exist in the human body. According to the lack of any significant new antifungal medication in past 10-15 years, introduction of inhibitors for this enzyme in our patent is valuable for developing of new antifungal medication. The embodiments herein provide a composition and a method of synthesizing a composition comprising an aliphatic amino acid biosynthesis inhibitor having an antifungal activity. The composition comprises 2-oxo-2H-chromen-7-yl propiolate, diethyl-hex-2-en-4-yne-dioate and dinonyl-hex-2-en-4-yne-dioate. The composition inhibits a biosynthesis of an aliphatic amino acid in a fungal biological system. The aliphatic amino acid is selected from a group consisting of leucine, isoleucine and valine. The composition is used with a concentration of 0-200 mug/ml. The method comprises mixing solutions of dicyclohexylcarbodiimide (DCC) and Dimethylaminopyridine (DMAP) with alcohol, acetylene carboxylic acid and dichloromethane to obtain a mixture which is stirred filtered and washed with ether.; The solvents are evaporated to obtain a residue that is dissolved in dichloromethane and stirred with a catalyst. The extra solvents are evaporated to obtain the derivative compound and purified by silica gel column chromatography.

Financial information

we would like to know you investment services on:
- licensing
-share holding
-total transfer of right
for patent.

we are interested to have more information in detail and the process.

[ Home | List a patent | Manage your account | F.A.Q.|Terms of use | Contact us]

Copyright 2004-2017
Page created at 2024-05-18 5:46:52, Patent Auction Time.